Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

digital marketing executive

Thousands missing out on diabetes tests

Thousands of diabetes patients are missing out on tests to help manage their disease according to the recently published National Diabetes Audit 

NHS Salford holds first Twitter interview

The first ever NHS Twitter interview generated discussion from 58 contributors and contained over 240 tweets

RCGP updates revalidation guide

The UK's Royal College of General Practitioners has published new revalidation guidance for GPs working in special circumstances

Draft NICE guidance rejects Tyverb for NHS

Draft NICE guidance has recommended against the use of GSK's breast cancer drug, Tyverb, outside clinical trials

Lansley pushes for patient-centred care

In his first speech as secretary of state for health, Andrew Lansley presented his vision for putting patients at the centre of UK healthcare

NHS Direct pilot to help treatment decisions

NHS Direct is piloting three online decision aids to help patients facing difficult decisions make informed healthcare choices

- PMLiVE

RCGP launches ‘Healthy Working UK’

The Royal College of General Practitioners has launched 'Healthy Working UK' – a website providing information concerning work and health

NICE recommends AZ’s Iressa for NSCLC

NICE has recommended AstraZeneca's Iressa as a first line treatment for non-small-cell lung cancer

The future for UK healthcare

A health bill that aims to create an NHS led by clinical decision makers will go before parliament in the next 18 months

MMR-autism ‘link’ doctor struck off

Dr Andrew Wakefield, who authored a 1998 Lancet study alleging a link between the MMR vaccine and autism, has been struck off by the GMC

UK government may end free drugs pricing

There are indications that free pricing for drugs may come under threat as part of cost-cutting processes by the Tory/Lib-Dem coalition government

Petition on Vidaza presented to No 10

A petition is being presented to the Prime Minister sparked by NICE's decision not to make Celgene's Vidaza available through the NHS

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links